Caitlin John LLC Takes Position in CME Group Inc. $CME

Key Points

• Caitlin John LLC acquired a new position in CME Group, purchasing 5,133 shares valued at about $1.4 million, which constitutes 1.3% of its portfolio.
• CME Group reported $2.96 earnings per share for its last quarter, exceeding analysts' expectations, with a year-over-year revenue increase of 10.4% to $1.69 billion.
• The company announced a quarterly dividend of $1.25 per share, resulting in a 1.9% yield, with the payment date set for September 25th.

Caitlin John LLC acquired a new position in shares of CME Group Inc. (NASDAQ:CME - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 5,133 shares of the financial services provider's stock, valued at approximately $1,415,000. CME Group makes up approximately 1.3% of Caitlin John LLC's portfolio, making the stock its 24th biggest holding.

Several other large investors have also modified their holdings of CME. Bank Pictet & Cie Europe AG boosted its stake in shares of CME Group by 29.0% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 86,941 shares of the financial services provider's stock worth $20,190,000 after acquiring an additional 19,533 shares in the last quarter. Focus Partners Advisor Solutions LLC boosted its stake in shares of CME Group by 61.0% during the 4th quarter. Focus Partners Advisor Solutions LLC now owns 1,671 shares of the financial services provider's stock worth $388,000 after acquiring an additional 633 shares in the last quarter. GTS Securities LLC boosted its stake in shares of CME Group by 186.2% during the 4th quarter. GTS Securities LLC now owns 3,039 shares of the financial services provider's stock worth $706,000 after acquiring an additional 6,566 shares in the last quarter. Putney Financial Group LLC bought a new stake in shares of CME Group during the 4th quarter worth $389,000. Finally, Ascent Group LLC boosted its stake in shares of CME Group by 22.8% during the 4th quarter. Ascent Group LLC now owns 16,969 shares of the financial services provider's stock worth $3,941,000 after acquiring an additional 3,147 shares in the last quarter. 87.75% of the stock is owned by institutional investors.

CME Group Price Performance

NASDAQ CME opened at $261.53 on Monday. CME Group Inc. has a fifty-two week low of $212.38 and a fifty-two week high of $290.79. The stock's 50-day moving average is $271.98 and its two-hundred day moving average is $270.81. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market cap of $94.25 billion, a P/E ratio of 25.32, a price-to-earnings-growth ratio of 4.73 and a beta of 0.43.

CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period last year, the company earned $2.56 earnings per share. The business's revenue was up 10.4% compared to the same quarter last year. On average, analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date is Tuesday, September 9th. CME Group's dividend payout ratio (DPR) is 48.40%.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on CME shares. Wall Street Zen lowered CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Barclays set a $298.00 price objective on CME Group and gave the stock an "equal weight" rating in a research note on Thursday, July 24th. UBS Group decreased their target price on CME Group from $305.00 to $285.00 and set a "neutral" rating for the company in a research report on Monday, September 8th. Oppenheimer raised their target price on CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research report on Thursday, July 24th. Finally, Citigroup raised their target price on CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a research report on Thursday, July 3rd. Four investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $260.60.

Insider Buying and Selling

In other CME Group news, insider Timothy Francis Mccourt sold 379 shares of the firm's stock in a transaction dated Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total transaction of $98,475.57. Following the transaction, the insider directly owned 9,508 shares in the company, valued at $2,470,463.64. This trade represents a 3.83% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Sunil Cutinho sold 11,896 shares of CME Group stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the transaction, the insider owned 17,440 shares in the company, valued at $4,734,436.80. The trade was a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 13,043 shares of company stock valued at $3,527,956 in the last three months. 0.30% of the stock is currently owned by corporate insiders.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.